Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Cal... ( EATONTOWN N.J. Feb. 15 /- Osteote...)

Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule

Date:2/15/2008

EATONTOWN, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE) announced today that the Company's fourth quarter and year ended December 31, 2007 financial results will be released Wednesday, February 20, 2008. A conference call will be conducted by Sam Owusu-Akyaw, President and Chief Executive Officer, as well as other members of Osteotech management, on Wednesday, February 20, 2008, at 9:00 a.m. Eastern time. You are invited to listen to the conference call by dialing 1-706-643-1624. Automated playback will be available two hours after completion of the live call through midnight, Wednesday, March 5, 2008 by dialing 1-706-645-9291 and indicating access code 34462919.

A live, listen-only webcast of our conference call will also be available at our investor site at http://www.osteotech.com on the Financial Highlights page. A replay of the conference call and the question/answer session will be available at the Company's website for approximately 14 days following the call. It will be necessary to have RealPlayer installed on your computer.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech, this press release or the conference call, please go to Osteotech's website at http://www.osteotech.com.

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/6/2009)...AN MATEO, Calif., Nov. 6 ...leted transfer of Qutenza(TM) E.U. Marketing Autho...nificant progress in commercial readiness activiti...Senior Director, Marketing; and Director, Commerci...ard as director and Audit Committee chairman ,...

(Date:11/6/2009)... The agenda for Arrowhead’...ce, which is set to take place on February 22-24, ...three day conference we will highlight key issues ...rs to share their experiences. , ...- The agenda for Arrowhead’s 2010 Personali...

(Date:11/5/2009)...ARSIPPANY, N.J., Nov. 5 DSM Pharma... a manufacturing alliance with Galenix, Saint Jean...commercial scale manufacturing partner for Galenix...and Galenix will collaborate on business developme...y technologies, based on the strength of Galenix i...

(Date:11/5/2009)...MAHA, Neb., Nov. 5 Trans...ounced financial results for the quarter ended Sep...re presented in the tables that follow. ,, Thi...loss of $366,000 or $0.01 per share for the third ...000 or $0.01 per share for the third quarter of 20...

[0] NeurogesX Reports Third Quarter 2009 Results [0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix [0] Transgenomic, Inc. Reports Third Quarter 2009 Results

...2 Nektar,Therapeutics (Nasdaq: NKTR ) announced ...nsition from a drug delivery service provider to a...estructuring will,streamline the company, consolid...aking and execution within the business units., "... development company,and these changes are a natur...

...formance in 2007 and Notes Achievements over 4-ye... BioSciences, Preparing for Cha...ing-Plough,Corporation (NYSE: SGP ) today reporte...d full year, and commented on its ongoing integrat...cquired in November 2007 and,includes the Organon ...

...nternational,Corporation (Nasdaq: PRXL ) announce... 2-for-1 split of its Common Stock, which will be ...ers of PAREXEL,s Common Stock will receive one add...mmon Stock held on the record date of,February 22,...n or about,March 3, 2008 by PAREXEL,s transfer age...

Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year PAREXEL International Announces 2-For-1 Stock Split

(Date:11/4/2009)... 2009 Childhood obesity in the United States is r...ourth of advertising on daytime and prime time tel...ing questions about the role television plays in o...the Journal of Nutrition Education and Behavior ...ght be a large contributor to the problem. , Res...

(Date:11/4/2009)...hat deciphered the DNA codes, or genomes, of the f...joined The Genome 10K Project, an international ef...ences on 10,000 species of animals for conducting ...not be achieved. , Participating in The Genome 1...Nov. 5, 2009 issue of the Journal of Heredity , a...

(Date:11/4/2009)..., Oct. 19 Spectros, developer and ...ging devices which shed light on life-threatening ...sive distribution deals for both its T-Stat® ...red include Australia, New Zealand, The Netherlan..., France, Spain, Portugal, Poland, Greece, Turkey,...

Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2 TV bombards children with commercials for high-fat and high-sugar foods 3 Singapore scientists join international study of 10,000 vertebrates' genomes 2 Spectros Signs New International Distribution Deals 2 Donor Sperm Providers Form New Non Profit 59569 1 Oaks Development Group Launches Physician Incubator Space in Palm Coast Medical Office Building 59566 1 Oaks Development Group Launches Physician Incubator Space in Palm Coast Medical Office Building 59566 2 MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 1 MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 2 MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 3

[0] TV bombards children with commercials for high-fat and high-sugar foods [0] Singapore scientists join international study of 10,000 vertebrates' genomes [0] Spectros Signs New International Distribution Deals

...reasing amounts of ice mass have been lost from We... past ten years, according to research from the Un... in Nature Geoscience. , Meanwhile the ice mass ...either loss nor accumulation over the past decade.... Bristol and colleagues estimated the flux of ice ...

...N ARBOR, Mich.---Common genetic variants linked to... new study shows. , The international study was c...ic Health. The journal Nature Genetics will publis...onfirms observations by health professionals of a ...risk of osteoarthritis, the most common form of ar...

...tudies involving more than 35,000 people and a sur...al team supported in part by the National Institut...genetic variants recently linked to osteoarthritis...indings were released today in the advance online ...e variants most strongly associated with height in...

Other Biology News:Antarctic ice loss 2 Study suggests genetic connection between short stature and arthritis 2 Researchers uncover new piece to the puzzle of human height 2 Researchers uncover new piece to the puzzle of human height 3 Researchers uncover new piece to the puzzle of human height 4

Antarctic ice loss Study suggests genetic connection between short stature and arthritis Researchers uncover new piece to the puzzle of human height

Duck Anti-Cobra venom - Fab Fragment Polyclonal Antibody, Unconjugated from Abcam

Fetuin from Equitech-Bio

Mouse Anti-JNK, phospho (Thr183 / Thr185) Antibody, Unconjugated from Raybiotech, Inc.

Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology

Biology Products:

Duck Anti-Cobra venom - Fab Fragment Polyclonal Antibody, Unconjugated from Abcam Fetuin from Equitech-Bio Mouse Anti-JNK, phospho (Thr183 / Thr185) Antibody, Unconjugated from Raybiotech, Inc.Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology

Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Cal...( EATONTOWN N.J. Feb. 15 /- Osteote...)